Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

December 26, 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

November 09, 2017

TCTMD’s Top 10 Most Popular Stories for October 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

October 29, 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

News Daily News

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Yael L. Maxwell

August 14, 2017

Closer Follow-up of Preeclampsia in Pregnancy Needed to Reduce Risk of Stroke

News Daily News

Closer Follow-up of Preeclampsia in Pregnancy Needed to Reduce Risk of Stroke

May 25, 2017

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

News Daily News

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

May 24, 2017

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

May 03, 2017

News Daily News

MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke

Michael O'Riordan

April 05, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

TCTMD’s Top 10 Most Popular Stories for January 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

February 01, 2017

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

September 03, 2009

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.